Leading Center of Excellence will participate in a 60-day evaluation of The Company’s signal processing technology Westport, CT, June 22, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal […]
Rhythm
Sheba Becomes First Clinic in Israel to be Authorized by Medtronic International to conduct MICRA Pacemaker Implant Training for Physicians
Sheba Joins a Small and Exclusive Group Of 15 Leading Medical Centers in Europe Authorized to Provide Training on this Unique Technology RAMAT GAN, Israel – June 22, 2022 – Sheba Medical Center, Israel’s largest medical center and a Newsweek top-10 ranked world’s best hospital for the last four years, […]
Study Demonstrates Cardiologs’ AI Can Predict Occurrence of Atrial Fibrillation in the Near Future
Newly published research shows that Cardiologs’ deep learning model can predict the short-term risk of atrial fibrillation (AFib) based on 24-hour Holter recordings that show normal sinus rhythm. PARIS and BOSTON, June 21, 2022 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced today that its latest study, “Short-term prediction of atrial […]
Texas Cardiac Arrhythmia Institute at St. David’s Medical Center hosted international conference on complex cardiac arrhythmias
AUSTIN, Texas, June 15, 2022 /PRNewswire/ — On June 2 and 3, 2022, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its sixth international symposium on complex arrhythmias, EPLive 2022. This year’s event had more than 1,250 people register, a record number, with more than 150 who attended in person. […]
Almost 1 In Every 4 Adult Male Deaths in the United States is Caused by Heart Disease and African American men account for 100,000 more Cardiovascular Disease Deaths than Caucasian Men
TAMPA, Fla., June 9, 2022 /PRNewswire/ — Smart Meter, continues to lead the way in the remote patient monitoring (RPM) sector because of its superior cellular-enabled devices and robust data that facilitate better care management. During Men’s Health Month, Smart Meter wants to remind patients and providers that high blood pressure and obesity, […]
MEDICALGORITHMICS secured FDA approval for Qpatch wearable
The US Food and Drug Administration has registered Qpatch, an ECG wearable unit developed by experts from Medicalgorithmics. The FDA approval allows use of ECG readings from Qpatch in the United States. WARSAW, Poland, June 9, 2022 /PRNewswire/ — Qpatch is a state-of-the-art wearable device for measuring individual ECG signal to obtain accurate […]
PZU Zdrowie (Eng. PZU Health) rolls out Cardiomatics solution for precise diagnostics in cardiology across their clinics.
CRACOW, Poland, June 8, 2022 /PRNewswire/ — The AI-based system developed by Cardiomatics streamlines the work of cardiologists by supporting ECG interpretation. Now, the doctors at PZU Zdrowie (a Polish healthcare provider associated with PZU Group – one of the top insurance companies in East-Central Europe) will be able to take advantage of its […]
AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial
Trial will evaluate the safety and effectiveness of AtriCure’s Isolator® Synergy™ Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain […]
ALLM announced as Get With The Guidelines® Compatible Vendor
CAMBRIDGE, Mass., June 06, 2022 (GLOBE NEWSWIRE) — ALLM announced today that it has been named a compatible vendor within the American Heart Association Get With The Guidelines® program. This premier AHA (American Heart Association) program assists hospitals in measuring and improving cardiovascular disease and stroke care through research-based methods, […]
Eagle Pharmaceuticals Announces Submission of New Drug Application to U.S. Food and Drug Administration for Landiolol, a Beta-1 Adrenergic Blocker
— Submission seeks approval for landiolol for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter — — Expected approval mid-year 2023, if accepted by FDA for filing, based on feedback from U.S. Food and Drug Administration (“FDA”) provided during AOP Health’s […]



